#United States #Class Action #Berger Montague #Viatris #Canonsburg, PA

Investors of Viatris Inc. Urged to Join Class Action Lawsuit

In a significant legal move, Berger Montague PC has announced a securities class action lawsuit against Viatris Inc., a prominent healthcare company that provides essential medicines globally. This lawsuit pertains to investors who purchased Viatris securities during the period from August 8, 2024, to February 26, 2025. Set against the backdrop of Viatris’s recent financial disclosures, this case highlights serious concerns regarding the company's operational integrity.

Background of the Case

Viatris, headquartered in Canonsburg, Pennsylvania, has been supplying life-saving medicines to around one billion patients worldwide. However, the company encountered serious difficulties as revealed in their recent financial results for the fourth quarter and full year of 2024, disclosed on February 27, 2025. Investors were taken aback by disappointing guidance for 2025, which the company attributed to the anticipated financial repercussions from a warning letter concerning its Indore facility and an associated import alert.

As outlined in the lawsuit, the announcement caused Viatris’s stock price to plummet significantly, dropping over 15% from $11.24 per share on February 26 to $9.53 per share the following day. This sharp decline underscores the critical nature of the allegations presented in the lawsuit, suggesting that the company may have failed to disclose vital information that could affect stock prices.

Call to Action for Investors

Investors who acquired Viatris securities during the specified class period are strongly encouraged to reach out to Berger Montague by June 3, 2025, if they wish to act as lead plaintiffs in the case. A lead plaintiff serves as a representative for all class members and typically is an investor or a small group of investors with the largest financial stake in the outcome of the litigation. Affected investors can either participate actively or choose to remain passive class members; however, engagement with any legal counsel is necessary if they want to take on the lead plaintiff role.

To explore your options or for additional information regarding your rights, interested parties are advised to communicate with Berger Montague. Senior Counsel Andrew Abramowitz and attorney Peter Hamner are available to answer queries and guide investors through the process.

The Role of Berger Montague

Since its inception in 1970, Berger Montague has been at the forefront of securities class action litigation, representing both individual and institutional investors for over five decades. The firm has diverse offices located in major U.S. cities including Philadelphia, Minneapolis, and San Francisco, affirming its widespread impact in the realm of investor protection.

It is crucial for investors affected by this significant drop in stock price to consider their legal options promptly to safeguard their rights and potential recovery. The firm encourages Viatris investors to act swiftly due to the approaching deadline. For insights into the ongoing case or to stake a claim in the class action suit, contacting Berger Montague is imperative.

In summary, the Viatris class action lawsuit stands as a pivotal opportunity for investors who have been impacted by potential misrepresentations regarding the company's performance. Navigating such legal frameworks can be challenging, but with trusted representation from Berger Montague, investors may find a viable path towards recovery and accountability.